CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows From Operating Activities:
Net (loss)/earnings	$ (11,908)	$ 2,267
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization, net	2,532	2,429
Deferred income taxes	(711)	(548)
Stock-based compensation	133	122
Impairment charges	1	20
Divestiture gains and royalties	(280)	(194)
Acquired IPRD	12,949	75
Equity investment (gains)/losses	(102)	155
Other adjustments	22	4
Changes in operating assets and liabilities:
Receivables	479	(175)
Inventories	(218)	(282)
Accounts payable	300	187
Rebates and discounts	(665)	(910)
Income taxes payable	910	884
Other	(608)	(1,064)
Net cash provided by operating activities	2,834	2,970
Cash Flows From Investing Activities:
Sale and maturities of marketable debt securities	747	57
Purchase of marketable debt securities	(274)	(200)
Proceeds from sales of equity investments	5	62
Capital expenditures	(284)	(278)
Divestiture and other proceeds	241	227
Acquisition and other payments, net of cash acquired	(20,053)	(78)
Net cash used in investing activities	(19,618)	(210)
Cash Flows From Financing Activities:
Short-term debt obligations, net	3,070	128
Issuance of long-term debt	12,883	0
Repayment of long-term debt	0	(1,640)
Repurchase of common stock	0	(250)
Dividends	(1,212)	(1,196)
Stock option proceeds and other, net	(97)	(92)
Net cash provided by/(used in) financing activities	14,644	(3,050)
Effect of exchange rates on cash, cash equivalents and restricted cash	(45)	13
Decrease in cash, cash equivalents and restricted cash	(2,185)	(277)
Cash, cash equivalents and restricted cash at beginning of period	11,519	9,325
Cash, cash equivalents and restricted cash at end of period	$ 9,334	$ 9,048